Fore Capital’s Pulse Biosciences PLSE Stock Holding History

Fore Capital’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,832	Closed	-$147K	–	73
2018 Q4	$147K	Buy	+12,832	New	+$155K	0.07%	51
2018 Q1	–	Sell	-10,000	Closed	-$236K	–	83
2017 Q4	$236K	Buy	+10,000	New	+$236K	0.09%	65

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

TIAA FSB Jacksonville, Florida $27.6B AUM 14.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fore Capital's PLSE Position: Q1 2019 in Review

Fore Capital sold out of Pulse Biosciences (PLSE) in Q1 2019, closing a stake of 12,832 shares — an estimated $147K sold.

Fore Capital first reported a position in PLSE in Q4 2017 and held it in 2 quarters. The position peaked at $236K in Q4 2017. 41 funds tracked by Wall St. Rank hold PLSE as of Q1 2019.

Fore Capital reported no remaining Pulse Biosciences position as of Q1 2019 after selling out during the quarter.
Fore Capital sold 12,832 Pulse Biosciences shares in Q1 2019, an estimated $147K.
Fore Capital first reported a position in Pulse Biosciences in Q4 2017 and held it in 2 quarters.
Fore Capital's Pulse Biosciences position peaked at $236K in Q4 2017.
41 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2019.

Based on Fore Capital's 13F filing for Q1 2019, filed 15 May 2019.